Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Imunon, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −4 vs. Q4 2023
- Shares held
- 335.5K
- −84.4K (−20.1%) vs. Q4 2023
- Total value
- $539.4K
- +$253.5K (+88.7%) vs. Q4 2023
- New holders
- 2
- 3 more added
- Sold out
- 6
- 5 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMNN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $506.1K |
| Q1 2026 | 19 | $1.63M |
| Q4 2025 | 20 | $1.76M |
| Q3 2025 | 17 | $879.0K |
| Q2 2025 | 26 | $1.76M |
| Q1 2025 | 19 | $359.9K |
| Q4 2024 | 22 | $403.5K |
| Q3 2024 | 22 | $1.08M |
| Q2 2024 | 18 | $442.0K |
| Q1 2024 | 18 | $539.4K |
| Q4 2023 | 22 | $285.9K |
| Q3 2023 | 18 | $402.9K |
| Q2 2023 | 17 | $515.1K |
| Q1 2023 | 19 | $513.3K |
| Q4 2022 | 22 | $572.7K |
| Q3 2022 | 22 | $818.1K |
| Q2 2022 | 25 | $1.69M |
| Q1 2022 | 24 | $2.66M |
| Q4 2021 | 42 | $4.14M |
| Q3 2021 | 40 | $8.54M |
| Q2 2021 | 43 | $11.5M |
| Q1 2021 | 47 | $16.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Imunon, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 105,811 | $174.0K | 0.00% | +13,700+14.9% | Added |
| Geode Capital Management, LLC | 66,595 | $109.3K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 58,222 | $95.5K | 0.00% | −362−0.6% | Reduced |
| Vanguard Group Inc | 48,806 | $80.0K | 0.00% | −2,213−4.3% | Reduced |
| Colony Group, LLC | 35,000 | $46.0K | 0.00% | +35,000 | New |
| State Street Corp | 14,303 | $23.5K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,342 | $7.12K | 0.00% | −3,923−47.5% | Reduced |
| Morgan Stanley | 1,631 | $2.67K | 0.00% | 00.0% | Unchanged |
| M&R Capital Management Inc | 333 | $546 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 145 | $238 | 0.00% | +139+2,316.7% | Added |
| Group One Trading, L.P. | 129 | $212 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 73 | $120 | 0.00% | +1+1.4% | Added |
| Federation des caisses Desjardins du Quebec | 66 | $108 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 46 | $75 | 0.00% | +46 | New |
| UBS Group AG | 21 | $34 | 0.00% | −5,875−99.6% | Reduced |
| Advisor Group Holdings, Inc. | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Game Plan Financial Advisors, LLC | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2 | $0 | 0.00% | −2−50.0% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −29,628−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −28,569−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,860−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −22,864−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,841−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −137−100.0% | Sold out |